NO924775D0 - Substituerte benzimidazoler, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse - Google Patents

Substituerte benzimidazoler, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse

Info

Publication number
NO924775D0
NO924775D0 NO924775A NO924775A NO924775D0 NO 924775 D0 NO924775 D0 NO 924775D0 NO 924775 A NO924775 A NO 924775A NO 924775 A NO924775 A NO 924775A NO 924775 D0 NO924775 D0 NO 924775D0
Authority
NO
Norway
Prior art keywords
procedures
preparation
pharmaceutical use
substituted benzimidazoles
benzimidazoles
Prior art date
Application number
NO924775A
Other languages
English (en)
Norwegian (no)
Other versions
NO924775L (no
Inventor
Arne Elof Braendstroem
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO924775D0 publication Critical patent/NO924775D0/no
Publication of NO924775L publication Critical patent/NO924775L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO92924775A 1990-06-20 1992-12-10 Substituerte benzimidazoler, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse NO924775L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds
PCT/SE1991/000415 WO1991019711A1 (en) 1990-06-20 1991-06-11 Substituted benzimidazoles, process for their preparation and their pharmaceutical use

Publications (2)

Publication Number Publication Date
NO924775D0 true NO924775D0 (no) 1992-12-10
NO924775L NO924775L (no) 1992-12-10

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924775A NO924775L (no) 1990-06-20 1992-12-10 Substituerte benzimidazoler, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse

Country Status (27)

Country Link
EP (1) EP0535081A1 (zh)
JP (1) JPH05507713A (zh)
CN (1) CN1058212A (zh)
AP (1) AP215A (zh)
AU (1) AU649453B2 (zh)
BG (1) BG97200A (zh)
CA (1) CA2083714A1 (zh)
CZ (1) CZ279772B6 (zh)
FI (1) FI925766A0 (zh)
HU (1) HUT62881A (zh)
IE (1) IE912025A1 (zh)
IL (1) IL98470A0 (zh)
IS (1) IS3721A7 (zh)
LT (2) LT3977B (zh)
LV (1) LV10953A (zh)
MA (1) MA22199A1 (zh)
NO (1) NO924775L (zh)
NZ (1) NZ238546A (zh)
OA (1) OA09682A (zh)
PT (1) PT98035A (zh)
RO (1) RO110493B1 (zh)
SE (1) SE9002206D0 (zh)
TN (1) TNSN91049A1 (zh)
TW (1) TW216418B (zh)
WO (1) WO1991019711A1 (zh)
YU (1) YU104191A (zh)
ZA (2) ZA914297B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
DK1257269T3 (da) 2000-02-24 2005-03-14 Kopran Res Lab Ltd Syrestabile benzimidazolderivater til oral indgivelse mod ulcus
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
ATE544447T1 (de) 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
RU2467747C2 (ru) 2006-07-25 2012-11-27 Векта Лтд. Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi
EP2065379A4 (en) * 2006-10-13 2011-01-19 Eisai R&D Man Co Ltd BENZIMIDAZOLE HAVING INHIBITORY ACTIVITY OF GASTRIC ACID SECRETION
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.
KR102409502B1 (ko) * 2016-09-14 2022-06-16 위펑 제인 쳉 D-아미노산 옥시다제 (daao) 저해제로서 신규한 치환된 벤즈이미다졸 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (zh) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
WO1989003830A1 (en) * 1987-10-30 1989-05-05 Aktiebolaget Hässle 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss
ZA889194B (en) * 1987-12-11 1989-08-30 Byk Gulden Lomberg Chemisch Fa Novel benzimidazole derivatives
JPH03504497A (ja) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規フルオルアルコキシ化合物

Also Published As

Publication number Publication date
ZA914296B (en) 1992-03-25
IE912025A1 (en) 1992-01-01
YU104191A (sh) 1994-01-20
AP215A (en) 1992-09-02
NZ238546A (en) 1994-03-25
TW216418B (zh) 1993-11-21
PT98035A (pt) 1992-03-31
CN1058212A (zh) 1992-01-29
LTIP1713A (en) 1995-08-25
CA2083714A1 (en) 1991-12-21
OA09682A (en) 1993-05-15
CS189491A3 (en) 1992-04-15
BG97200A (bg) 1993-12-24
IL98470A0 (en) 1992-07-15
FI925766A (fi) 1992-12-18
LT3977B (en) 1996-06-25
HU9204033D0 (en) 1993-03-29
LTIP1712A (en) 1995-08-25
JPH05507713A (ja) 1993-11-04
MA22199A1 (fr) 1992-04-01
AU8009791A (en) 1992-01-07
CZ279772B6 (cs) 1995-06-14
RO110493B1 (ro) 1996-01-30
WO1991019711A1 (en) 1991-12-26
LT3952B (en) 1996-05-27
EP0535081A1 (en) 1993-04-07
HUT62881A (en) 1993-06-28
NO924775L (no) 1992-12-10
ZA914297B (en) 1992-03-25
TNSN91049A1 (fr) 1992-10-25
AU649453B2 (en) 1994-05-26
AP9100285A0 (en) 1991-07-31
LV10953A (lv) 1995-12-20
IS3721A7 (is) 1991-12-21
FI925766A0 (fi) 1992-12-18
SE9002206D0 (sv) 1990-06-20

Similar Documents

Publication Publication Date Title
NO924775D0 (no) Substituerte benzimidazoler, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO904551D0 (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
NO910003L (no) Vitamin e-derivater og fremgangsmaate for deres fremstilling.
NO915105D0 (no) Organiske kopolymerer, fremgangsmaate for deres fremstilling og anvendelse
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
NO914288L (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
DK530689D0 (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO921563L (no) Terapeutisk aktive aminopyrimidinderivater, fremgangsmaatefor deres fremstilling og anvendelse derav
NO904552L (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
NO951811D0 (no) Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse
NO872625D0 (no) Benzimidazoler og fremgangsmaater for deres fremstilling.
NO911047D0 (no) Labdaner og fremgangsmaate for deres fremstilling.
NO900252L (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
NO893565L (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO924563L (no) Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser
NO920258D0 (no) Adenosinderivater, fremgangsmaate for deres fremstilling og anvendelse derav
NO912526L (no) Cefalosporinderivater og fremgangsmaate for deres fremstilling.
NO924087D0 (no) Antistoffer, fremgangsmaate for deres fremstilling og anvendelse derav
EE02980B1 (et) Bensimidasooli derivaadid, nende valmistamine ja kasutamine
DK617689A (da) (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spirooe4h-1-benzopyran-4,4'-imidazolidinaa-2-carboxamidderivater, fremgangsmaade til deres fremstilling og deres anvendelse